Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling

Diabetologia

Volumn 45, Issue 5, 2002, Pages 635-641

  Herlihy, O ^a   Barrow, B ^a   Grant, P ^b   Levy, J ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Blood coagulation; Central obesity; Fibrinolysis; Hyperglycaemia; Insulin sensitivity; Lipids; PAI 1; Sibling; Tissue plasminogen activator; Type II diabetes

Indexed keywords

C PEPTIDE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROINSULIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; LIPID; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET; REFERENCE VALUE; SECRETION; SIBLING; SMOKING; ADULT; AGED; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC OBESITY; DIET RESTRICTION; FAMILIAL DISEASE; FAMILY HISTORY; INSULIN SENSITIVITY; PRIORITY JOURNAL;

BLOOD GLUCOSE; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROINSULIN; REFERENCE VALUES; SIBLINGS; SMOKING; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; HUMAN; MIDDLE AGE; OBESITY IN DIABETES;

EID: 0035985075     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0795-8     Document Type: Article

References (33)

1. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study
2. Diabetes and cardiovascular disease. The Framingham study
3. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up
4. Haemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
5. Haemostatic function and ischemic heart disease: Principle results of the North Park heart study
6. Fibrinolysis and atherosclerosis
7. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death
8. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus
9. Haemostatic variables associared with diabetes and its complications
10. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients
11. Features of syndrome x in first-degree relatives of NIDDM patients
12. Parental history of diabetes is associated with increased cardiovascular risk factors
13. Obesity, insulin resistance, and its links to non-insulin dependent diabetes mellitus
14. The relative risk of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus
15. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1
16. Elevated fibrinogen and plasminogen activator inhibitors (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease
17. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM
18. PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: Metabolic and genetic associations
19. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
20. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes
21. UK prospective diabetes study XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects
22. Gerinnungsphysiologische scnellmethode zur bestimmung des fibrinogens
23. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates
24. High plasma insulin and triglyceride concentrations and blood pressure in offspring of people with impaired glucose tolerance
25. In vivo insulin action is familial characteristic in nondiabetic Pima Indians
26. Associations of body composition with Type 2 diabetes mellitus
27. Prevelance of diabetes mellitus, coronary heart disease and hypertension in the families of insulin depedent and insulin independent diabetes
28. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring study
29. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis
30. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
31. Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension
32. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
33. Correct homeostasis model assessment (HOMA) evaluation uses the computer program